The Prevalence of Contact Allergies for Wound Dressings In Patients With Diabetic Foot Ulcers (PAID Study)
NCT ID: NCT04085705
Last Updated: 2021-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
139 participants
OBSERVATIONAL
2019-09-17
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: To determine the prevalence of contact allergies for wound dressings in patients with diabetic foot ulcers.
Study design: A prospective multicenter study.
Study population: Patients (n=139) with diabetic foot ulcers caused by type 1 or 2 diabetes mellitus treated at Rijnstate Hospital Arnhem, the Netherlands.
Main study parameters/endpoints: The primary study parameter is the presence of contact allergies for wound dressings.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: An allergy test is standard procedure at Rijnstate Hospital, there is no direct technique-related burden or risk for the patient. In addition, wound dressings can be adjusted in patients where a contact allergy is determined which will benefit the prognosis of these patients. The data of this study will give insight in the prevalence of contact allergies for wound dressings in patients with diabetic foot ulcers.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The underlying mechanism of diabetic foot ulcers is most often solely neuropathy (60 to 70%), 15 to 20% have peripheral artery disease (PAD) only, and 15 to 20% have a mixture of both.4 Diabetic foot is more prevalent in males and more prevalent in type 2 diabetes than in type 1 diabetes3. Ulcers in patients without diabetes are mostly caused by venous insufficiency.5
Ulcers have a slow healing tendency. Around 15 percent of diabetic patients with an ulcer eventually have to amputate (a part of) the leg.1 Good wound care is therefore important. However, wound care can be delayed in the presence of a contact allergy. Contact allergy (synonym for contact sensitivity) is defined as an altered immune status of an individual induced by a particular sensitizing substance, a contact allergen. An individual in whom contact allergy has been induced will develop a secondary immune response if there is skin exposure to the same (or cross-reacting) allergen. This process is called elicitation, and will manifest as allergic contact dermatitis (type IV hypersensitivity).6 Allergic contact dermatitis, also termed allergic contact eczema, is defined as an inflammatory skin reaction caused by direct contact with noxious agents in the environment as a result of contact allergy.
Among patients with venous leg ulcers contact allergies is seen in around 50 percent of which 10-20% for wound dressings.7-10 The prevalence of contact allergies is getting higher and also increasing with the duration of the ulcer. 8,10 Wound dressings can cause allergic contact eczema (allergic contact dermatitis).
At present, the prevalence of contact allergies for wound dressings in diabetic patients with foot ulcers is unknown. With this study we want to gain insight in the prevalence of contact allergies in patients with diabetic foot ulcers and investigate if the prevalence of contact allergies among diabetic patients is as high as the prevalence in patients with venous leg ulcers.
Objective of the study:
The primary objective of this study is to determine the prevalence of contact allergies in patients with diabetic foot ulcers.
Study design:
This is a prospective, multi-centre study.
Study population:
The study population are high risk diabetic patients with a foot ulcer visiting the multidisciplinary consultation hour for diabetics at the clinic.
Diabetic patients are patients diagnosed with type 1 or type 2 diabetes.
Primary study parameters/outcome of the study:
The presence of contact allergy for wound dressings
Secundary study parameters/outcome of the study (if applicable):
The following factors will be gathered at baseline:
* Age
* Gender
* Diabetes type
* Duration of diabetes
* Medication use
* Ulcer characteristics like type, size, duration, progress (TEXAS classification)
* Number of past foot ulcers
* Duration of past foot ulcers
* Known allergies or atopy constitution
* Presence of allergic contact dermatitis around the wound
* Doses corticosteroid or antihistaminic therapy (not during PATCH testing)
* History of eczema
Parameters to define if there are other mechanisms besides diabetics underlying the ulcer:
* Ankle brachial index , toe pressure measurement or Transcutaneous oxygen pressure (TcPo2)
* Venous insufficiency which is measured by a venous duplex, if applicable
Parameters related with contact allergy or parameters that can influence the development of a contact allergy:
* Known allergy. If yes, which allergy/allergies?
* Duration of current ulcus cruris
* Number of past ulcers
* Treatment with wound dressing(s) current episode:
* Duration of ulcer
* Treatment with wound dressing(s) prior episode(s)
* Prevalence of allergic contact dermatitis
Nature and extent of the burden and risks associated with participation, benefit and group relatedness (if applicable):
Not applicable
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with diabetic foot ulcers
All patients with diabetic foot ulcers will undergo a PATCH test to determine the prevalence of contact allergies against wound dressings.
PATCH test
The PATCH test is a method used to determine whether a specific substance causes allergic inflammation of a patient's skin, in this case contact allergy for wound dressings. Two days after PATCH test is applied, the patches are removed. The next day, the presence of a contact allergy is determined.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PATCH test
The PATCH test is a method used to determine whether a specific substance causes allergic inflammation of a patient's skin, in this case contact allergy for wound dressings. Two days after PATCH test is applied, the patches are removed. The next day, the presence of a contact allergy is determined.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with type 1 or 2 diabetes mellitus;
* Diagnosed with diabetic foot ulcer;
* Provided written informed consent.
Exclusion Criteria
* Patient receiving systemic corticosteroid therapy during PATCH testing (patient should stop with corticosteroid therapy three days before PATCH testing, and may start when testing and reading is done)
* Patient receiving antihistaminic therapy during PATCH testing (patient should stop with antihistaminic therapy three days before PATCH testing, and may start when testing and reading is done)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rijnstate Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Birgitte Visch MD
Principal Investigaor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Birgitte Visch, MD
Role: PRINCIPAL_INVESTIGATOR
Rijnstate
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rijnstate
Arnhem, Gelderland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Visch BM, Veen DV, Smeets L, Toeter R, Bon AV, Romijn D. The Prevalence of Contact Allergies for Wound Dressings in Patients With Diabetic Foot Ulcers (PAID Study), an Observational Prospective Trial. Int J Low Extrem Wounds. 2025 Apr 10:15347346251332028. doi: 10.1177/15347346251332028. Online ahead of print.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PAID study
Identifier Type: -
Identifier Source: org_study_id